The American GDP dropped at an estimated 0.5 percent annual rate in Q1 2025, per the Commerce Department’s Bureau of Economic Analysis. That’s down from 2.4 percent growth the prior quarter (Q4 2024) and around 3 percent growth in both Q2 and Q3 2024.

Goldman Sachs is building a private credit product for retirement plans, joining a broad push by money managers to get their alternative investments into retirement portfolios and capitalize on a period of loosening regulation.

Commerce Department officials are discussing a new fee based on patent value, which could fuel backlash from businesses.

Goldman Sachs has decided to scrap a second round of planned job cuts this year after its investment banking unit produced stronger-than-expected results in the second quarter, according to a report..

Despite many of the “Liberation Day” tariffs having been paused for the past three months while trade negotiations were ongoing, the tariffs that remained in effect, e.g. a 10-percent baseline tariff on nearly all U.

Jonny Fine, Goldman Sachs global head investment grade credit, joins CNBC's 'Squawk on the Street' to discuss outlooks on capital markets, whether issuers are counting on rate cuts, and much more.

For one, Goldman CEO David Solomon doesn’t like overpaying, which is exactly what he’d have to do at this point to get Northern Trust to sell.

“During the last 35 years, other sharp increases in speculative trading activity have signaled above-average subsequent 3-, 6-, and 12-month S&P 500 returns, but returns typically faltered on a 24-month horizon,” says Goldman.

Salveen Richter, Goldman Sachs lead biotech analyst, joins 'Squawk Box' to discuss the troubles facing Sarepta and its muscular dystrophy drug Elevidys, state of the biotech sector, what to expect on earnings next week,

Goldman Sachs economists reportedly expect baseline U.S. reciprocal tariffs to rise to 15% from 10%, with 50% tariffs on copper and other critical minerals, which could stunt the country’s economic growth.